Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (121-130 of 239) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitroJ J Burge, D T Fearon, K F Austen
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytesJ K Czop, D T Fearon, K F Austen
Springer Seminars in Immunopathology|January 1, 1983
The role of antibody in the activation of the alternative complement pathwayW D Ratnoff, D T Fearon, K F Austen
The Journal of Allergy and Clinical Immunology|December 1, 1987
Hereditary angioedema: a decade of management with stanozololA L Sheffer, D T Fearon, K F Austen
Biotechnology and Applied Biochemistry|February 16, 2012
siRNA high-throughput kinase library screen identifies protein kinase, DNA-activated catalytic polypeptide to play a role in MyD88-induced IFNA2 activation and IL-8 secretionNikolaos Charlaftis, Douglas T Fearon, Annett Schoenemeyer, et al.
Cancer Immunology Research|April 30, 2014
Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1James N Arnold, Lukasz Magiera, Matthew Kraman, et al.
The Journal of Experimental Medicine|November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytesC C Delibrias, J E Floettmann, M Rowe, et al.
The New England Journal of Medicine|May 1, 1975
Activation of the properdin pathway of complement in patients with gram-negative bacteremiaD T Fearon, S Ruddy, P H Schur, et al.
The Journal of Experimental Medicine|December 20, 2000
Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6R Reljic, S D Wagner, L J Peakman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
The signaling activity of murine CD19 is regulated during cell developmentI Krop, A L Shaffer, D T Fearon, et al.
Pageof 24

Showing results (121-130 of 239) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Inhibition of the alternative pathway of complement by gold sodium thiomalate in vitroJ J Burge, D T Fearon, K F Austen
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytesJ K Czop, D T Fearon, K F Austen
Springer Seminars in Immunopathology|January 1, 1983
The role of antibody in the activation of the alternative complement pathwayW D Ratnoff, D T Fearon, K F Austen
The Journal of Allergy and Clinical Immunology|December 1, 1987
Hereditary angioedema: a decade of management with stanozololA L Sheffer, D T Fearon, K F Austen
Biotechnology and Applied Biochemistry|February 16, 2012
siRNA high-throughput kinase library screen identifies protein kinase, DNA-activated catalytic polypeptide to play a role in MyD88-induced IFNA2 activation and IL-8 secretionNikolaos Charlaftis, Douglas T Fearon, Annett Schoenemeyer, et al.
Cancer Immunology Research|April 30, 2014
Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1James N Arnold, Lukasz Magiera, Matthew Kraman, et al.
The Journal of Experimental Medicine|November 14, 1997
Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytesC C Delibrias, J E Floettmann, M Rowe, et al.
The New England Journal of Medicine|May 1, 1975
Activation of the properdin pathway of complement in patients with gram-negative bacteremiaD T Fearon, S Ruddy, P H Schur, et al.
The Journal of Experimental Medicine|December 20, 2000
Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6R Reljic, S D Wagner, L J Peakman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
The signaling activity of murine CD19 is regulated during cell developmentI Krop, A L Shaffer, D T Fearon, et al.
Pageof 24